Q BioMed Inc (QBIO)

[koen2]

i agree way to cheap

Look at AXSM also biotech with no revenue yet valued at $2.75 billion
Funny that is 100 times market cap of QBIO.

They are burning trough 12.5 million a quarter.
QBIO only $2 million a quarter

Only difference NADAQ

And QBIO is going to have revenue by the first quarter of 2020.
If the can run break even on the metastron and generic version we can keep the burn rate under control. they could even make profit on that side by the end of 2020.

Also take notice of the grant from the government of Germany for there Manin facility.that is the way to keep the debt under control.


Do the math when only one drug can make it to the market from the rest of the pipeline

you are talking $50 stock trading on NASDAQ
But therefore everything has to fall in place.

Let's take this one step at a time.